목요일, 12월 12, 2024
HomeMedical NewsPharmalittle: Purdue chapter ruling, a Merck rejection, and extra

Pharmalittle: Purdue chapter ruling, a Merck rejection, and extra


And so, one other working week will quickly draw to a detailed. Not a second too quickly, sure? That is, you could recall, our treasured sign to daydream about weekend plans. Our agenda is pretty modest. We hope to make amends for our studying, spend time with our Pharmalot ancestor, and promenade with the official mascots. We additionally hope to carry one other listening social gathering, the place the rotation will seemingly characteristic this, this, this, this, and this. And what about you? This can be a grand time to benefit from the nice open air. Seashores and lakes are beckoning. Metropolis streets wish to be strolled. And woods are inviting the adventurous for lengthy mysterious walks. Take your decide. Or you may merely cover indoors and binge-watch one thing on the telly. Properly, no matter you do, have a grand time. However be protected. Get pleasure from, and see you quickly …

The U.S. Supreme Court docket rejected a chapter deal wherein the homeowners of Purdue Pharma sought to contribute as much as $6 billion in change for immunity from additional lawsuits, STAT stories. The ruling means the corporate and its collectors — together with quite a few state and native governments — should negotiate a brand new settlement. The 5-4 determination was a rebuke to members of the Sackler household, who management the corporate and demanded the authorized defend in return for contributing to the deal though, as people, they didn’t file for chapter. The immunity was an enormous sticking level and prevented the deal, authorized by a chapter choose three years in the past, from being finalized.

A U.S. Home committee overwhelmingly handed 4 payments that might broaden Medicare protection of weight problems medication and most cancers screening blood checks and place guardrails round Medicare’s discretion in protecting medication and units authorized by the Meals and Drug Administration, STAT writes. The Home Methods & Means Committee handed weight problems drug protection laws that might supply a restricted pathway for adults 65 and older to get their weight reduction medication paid for by Medicare. Proper now, Medicare is prohibited from protecting drugs used for weight reduction, like Wegovy and Zepbound.

STAT+ Unique Story





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and networking platform entry.

Have already got an account? Log in

Have already got an account? Log in

View All Plans

Get limitless entry to award-winning journalism and unique occasions.

Subscribe



RELATED ARTICLES
RELATED ARTICLES

Most Popular